Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis-Reference-Cited by-同舟云学术

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

Published:2001-01 Issue:1 Volume:112 Page:228-236
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Craddock C.,Szydlo R. M.,Dazzi F.,Olavarria E.,Cwynarski K.,Yong A.,Brookes P.,De La Fuente J.,Kanfer E.,Apperley J. F.,Goldman J. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02519.x/fullpdf

Reference46 articles.

1. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality;Bacigalupo;Bone Marrow Transplantation,1995

2. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus;Beatty;Blood,1993

3. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains;Beersma;Journal of Immunology,1993

4. Increased transplant related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation;Broers;Blood,2000

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance over cytomegalovirus (CMV) reactivation following hematopoietic stem cell transplantation: a single-center experience;Biotechnology & Biotechnological Equipment;2024-03-18

2. Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT);Transplantation and Cellular Therapy;2024-01

3. Viral monitoring in immunocompromised hosts;Molecular Medical Microbiology;2024

4. Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: A Single-Centre Experience;Clinical Lymphoma Myeloma and Leukemia;2023-01

5. The changing impact of cytomegalovirus among hematopoietic cell transplant recipients during the past decade: A single institutional cohort study;Transplant Infectious Disease;2022-04-08